These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 38187038

  • 21. Histone deacetylase inhibitor-mediated sensitization to TRAIL-induced apoptosis in childhood malignancies is not associated with upregulation of TRAIL receptor expression, but with potentiated caspase-8 activation.
    Sonnemann J, Trommer N, Becker S, Wittig S, Grauel D, Palani CD, Beck JF.
    Cancer Biol Ther; 2012 Apr; 13(6):417-24. PubMed ID: 22313685
    [Abstract] [Full Text] [Related]

  • 22. Preclinical studies with ONC201/TIC10 and lurbinectedin as a novel combination therapy in small cell lung cancer (SCLC).
    Liguori NR, Sanchez Sevilla Uruchurtu A, Zhang L, Abbas AE, Lee YS, Zhou L, Azzoli CG, El-Deiry WS.
    Am J Cancer Res; 2022 Apr; 12(2):729-743. PubMed ID: 35261798
    [Abstract] [Full Text] [Related]

  • 23. DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines.
    LaBonte MJ, Wilson PM, Fazzone W, Groshen S, Lenz HJ, Ladner RD.
    BMC Med Genomics; 2009 Nov 30; 2():67. PubMed ID: 19948057
    [Abstract] [Full Text] [Related]

  • 24. GABA production induced by imipridones is a targetable and imageable metabolic alteration in diffuse midline gliomas.
    Batsios G, Udutha S, Taglang C, Gillespie AM, Lau B, Ji S, Phoenix T, Mueller S, Venneti S, Koschmann C, Viswanath P.
    bioRxiv; 2024 Jun 10. PubMed ID: 38915617
    [Abstract] [Full Text] [Related]

  • 25. Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways.
    Sampson VB, Vetter NS, Kamara DF, Collier AB, Gresh RC, Kolb EA.
    PLoS One; 2015 Jun 10; 10(11):e0142704. PubMed ID: 26571493
    [Abstract] [Full Text] [Related]

  • 26. Imipridones inhibit tumor growth and improve survival in an orthotopic liver metastasis mouse model of human uveal melanoma.
    Chattopadhyay C, Roszik J, Bhattacharya R, Alauddin M, Mahmud I, Yadugiri S, Ali MM, Khan FS, Prabhu VV, Lorenzi PL, Wei B, Burton E, Morey RR, Lazcano R, Davies MA, Patel SP, Grimm EA.
    Br J Cancer; 2024 Dec 10; 131(11):1846-1857. PubMed ID: 39394450
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis.
    Ma Y, Baltezor M, Rajewski L, Crow J, Samuel G, Staggs VS, Chastain KM, Toretsky JA, Weir SJ, Godwin AK.
    J Mol Med (Berl); 2019 Jul 10; 97(7):957-972. PubMed ID: 31025088
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Entinostat is a histone deacetylase inhibitor selective for class 1 histone deacetylases and activates HIV production from latently infected primary T cells.
    Wightman F, Lu HK, Solomon AE, Saleh S, Harman AN, Cunningham AL, Gray L, Churchill M, Cameron PU, Dear AE, Lewin SR.
    AIDS; 2013 Nov 28; 27(18):2853-62. PubMed ID: 24189584
    [Abstract] [Full Text] [Related]

  • 35. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
    Dos Santos MP, de Farias CB, Roesler R, Brunetto AL, Abujamra AL.
    Oncol Rep; 2014 Feb 28; 31(2):955-68. PubMed ID: 24316794
    [Abstract] [Full Text] [Related]

  • 36. The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators.
    Beider K, Bitner H, Voevoda-Dimenshtein V, Rosenberg E, Sirovsky Y, Magen H, Canaani J, Ostrovsky O, Shilo N, Shimoni A, Abraham M, Weiss L, Milyavsky M, Peled A, Nagler A.
    Biochem Pharmacol; 2019 Oct 28; 168():412-428. PubMed ID: 31325448
    [Abstract] [Full Text] [Related]

  • 37. Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies.
    Prabhu VV, Talekar MK, Lulla AR, Kline CLB, Zhou L, Hall J, Van den Heuvel APJ, Dicker DT, Babar J, Grupp SA, Garnett MJ, McDermott U, Benes CH, Pu JJ, Claxton DF, Khan N, Oster W, Allen JE, El-Deiry WS.
    Cell Cycle; 2018 Oct 28; 17(4):468-478. PubMed ID: 29157092
    [Abstract] [Full Text] [Related]

  • 38. Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma.
    Nguyen TTT, Shang E, Schiffgens S, Torrini C, Shu C, Akman HO, Prabhu VV, Allen JE, Westhoff MA, Karpel-Massler G, Siegelin MD.
    Clin Cancer Res; 2022 May 02; 28(9):1881-1895. PubMed ID: 35417530
    [Abstract] [Full Text] [Related]

  • 39. Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis.
    Schmidt O, Nehls N, Prexler C, von Heyking K, Groll T, Pardon K, Garcia HD, Hensel T, Gürgen D, Henssen AG, Eggert A, Steiger K, Burdach S, Richter GHS.
    J Exp Clin Cancer Res; 2021 Oct 15; 40(1):322. PubMed ID: 34654445
    [Abstract] [Full Text] [Related]

  • 40. ONC206, an Imipridone Derivative, Induces Cell Death Through Activation of the Integrated Stress Response in Serous Endometrial Cancer In Vitro.
    Zhang Y, Huang Y, Yin Y, Fan Y, Sun W, Zhao X, Tucker K, Staley A, Paraghamian S, Hawkins G, Prabhu V, Allen JE, Zhou C, Bae-Jump V.
    Front Oncol; 2020 Oct 15; 10():577141. PubMed ID: 33194693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.